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SCIENTIFIC OPINION 
Scientific Opinion on the substantiation of health claims related to fruits 
and/or vegetables (ID 1212, 1213, 1214, 1217, 1218, 1219, 1301, 1425, 1426, 
1427, 1428, 1429, 1430) and to the “Mediterranean diet” (ID 1423) 
pursuant to Article 13(1) of Regulation (EC) No 1924/2006
1
 
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
2, 3
 
European Food Safety Authority (EFSA), Parma, Italy 
SUMMARY 
Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and 
Allergies was asked to provide a scientific opinion on a list of health claims pursuant to Article 13 of 
Regulation (EC) No 1924/2006. This opinion addresses the scientific substantiation of health claims 
in relation to fruits and/or vegetables and to the “Mediterranean diet”. The scientific substantiation is 
based on the information provided by the Member States in the consolidated list of Article 13 health 
claims and references that EFSA has received from Member States or directly from stakeholders. 
Fruits and/or vegetables  
The foods that are the subject of the health claims are “fruits (fresh, frozen, canned, bottled, dried, 
juiced)”, “fruit-rich diet”, “vegetables (fresh, frozen, canned, bottled, dried, juiced)”, “vegetable-rich 
diet”, and “fruits and vegetables” related to the following claimed effects: cardiac function, weight 
management, and blood glucose control. 
The Panel notes that the type and amount of the specific fruits/vegetables and/or of the fruit/vegetable 
products required to obtain the claimed effects have not been indicated in the information provided; 
that the macro- and micronutrient composition, and the energy density, of different fruits and fruit 
products, and of different vegetables and vegetable products, is very variable; and that the significant 
differences in composition existing between such fruit/vegetable products may have an impact on the 
claimed effects. The Panel also notes that the health effects of “fruit-rich” and “vegetable-rich” diets 
                                                     
1  On request from the European Commission, Question No EFSA-Q-2008-1950, EFSA-Q-2008-1951, EFSA-Q-2008-1952, 
EFSA-Q-2008-1955, EFSA-Q-2008-1956, EFSA-Q-2008-1957, EFSA-Q-2008-2039, EFSA-Q-2008-2160, EFSA-Q-
2008-2162, EFSA-Q-2008-2163, EFSA-Q-2008-2164, EFSA-Q-2008-2165, EFSA-Q-2008-2166, EFSA-Q-2008-2167, 
adopted on 08 April 2011. 
2  Panel members: Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Hannu Korhonen, 
Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Monika Neuhäuser-Berthold, 
Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Daniel Tomé, 
Hendrik van Loveren and Hans Verhagen. Correspondence: nda@efsa.europa.eu 
3  Acknowledgement: The Panel wishes to thank the members of the Working Group on Claims for the preparatory work on 
this scientific opinion: Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Marina 
Heinonen, Hannu Korhonen, Martinus Løvik, Ambroise Martin, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, 
Sean (J.J.) Strain, Inge Tetens, Hendrik van Loveren and Hans Verhagen. 
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may depend on the overall characteristics (e.g. energy, energy density, and macronutrient 
composition) of such diets as influenced by other foods.  
The references submitted for the scientific substantiation of the health claims included narrative 
reviews and consensus opinions which addressed the association between dietary patterns and 
lifestyle factors (e.g. physical activity) on the risk of chronic disease, including coronary heart 
disease, obesity and type 2 diabetes. Dietary patterns which include a high consumption of fruits and 
vegetables have been associated with a decreased risk of chronic diseases (e.g. coronary heart disease, 
obesity and type 2 diabetes) as compared to dietary patterns, amongst others, characterised by low 
consumption of fruits and vegetables. However, the food items which are included in the “fruit” and 
“vegetable” categories are generally not reported in these studies, and the evidence provided by these 
studies relates to overall dietary patterns rather than to an effect of “fruit” and “vegetable” 
consumption independent of other dietary modifications. Accordingly, dietary recommendations for 
the primary prevention of such diseases generally include consumption of a diet rich in fruits and 
vegetables, together with an appropriate intake of other foods to achieve dietary balance of fat/fatty 
acids, carbohydrates, adequate intake of dietary fibre and limited intake of sodium and alcohol. 
The Panel considers that because of the high variety of the foods and food products that are the 
subject of the health claims, “fruits (fresh, frozen, canned, bottled, dried, juiced)”, “fruit-rich diet”, 
“vegetables (fresh, frozen, canned, bottled, dried, juiced)”, “vegetable-rich diet”, “fruits and 
vegetables”, these foods are not sufficiently characterised in relation to the claimed effects proposed. 
On the basis of the data presented, the Panel concludes that a cause and effect relationship cannot be 
established between the consumption of “fruits (fresh, frozen, canned, bottled, dried, juiced)”, “fruit-
rich diet”, “vegetables (fresh, frozen, canned, bottled, dried, juiced)”, “vegetable-rich diet” or “fruits 
and vegetables” and the claimed effects proposed because of the insufficient characterisation of these 
food categories and diets. 
“Mediterranean diet” 
The diet that is the subject of the health claim is the “Mediterranean diet” related to the following 
claimed effect: cardiac function. 
The characterisation provided by Member States specifies such diet as “based on high consumption of 
fruits, vegetables, cereals, pulses, nuts and seeds; moderate consumption of dairy products, fish, 
poultry and eggs and little use of red meat; low to moderate amount of wine; olive oil is the main 
cooking and dressing oil”. However, the Panel notes that quantitative amounts and appropriate 
characterisation of the food items or food groups listed have not been provided, and that no reference 
to the macronutrient composition (including dietary fibre) of the diet has been made. The Panel also 
notes that wine, which is listed as one of the components of the “Mediterranean diet”, contains more 
than 1.2 % alcohol by volume and therefore should not bear health claims in accordance with 
Regulation (EC) No 1924/2006.  
The Panel notes that different definitions of “Mediterranean diet” have been used in the references 
provided, and that therefore, the diet, which is the subject of the health claim, is unclear.  
The Panel considers that the diet, “Mediterranean diet”, which is the subject of the health claim, is not 
sufficiently characterised.  
On the basis of the data presented, the Panel concludes that a cause and effect relationship cannot be 
established between the consumption of a “Mediterranean diet” and the claimed effect proposed 
because of the insufficient characterisation of the term “Mediterranean diet”.  
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INFORMATION AS PROVIDED IN THE CONSOLIDATED LIST 
The consolidated list of health claims pursuant to Article 13 of Regulation (EC) No 1924/2006
4
 
submitted by Member States contains main entry claims with corresponding conditions of use and 
literature for similar health claims. EFSA has screened all health claims contained in the original 
consolidated list of Article 13 health claims which was received by EFSA in 2008 using six criteria 
established by the NDA Panel to identify claims for which EFSA considered sufficient information 
had been provided for evaluation and those for which more information or clarification was needed 
before evaluation could be carried out
5
. The clarifications which were received by EFSA through the 
screening process have been included in the consolidated list. This additional information will serve 
as clarification to the originally provided information. The information provided in the consolidated 
list for the health claims which are the subject of this opinion is tabulated in Appendix C. 
ASSESSMENT 
The approach used in the evaluation of Article 13(1) health claims is explained in the general 
guidance for stakeholders on the evaluation of Article 13.1, 13.5 and 14 health claims
6
.  
In assessing each specific food/health relationship that forms the basis of a health claim the NDA 
Panel considers the extent to which:   
1. the food/constituent is defined and characterised;  
2. the claimed effect is defined and is a beneficial physiological effect (“beneficial to human health”);   
3. a cause and effect relationship is established between the consumption of the food/constituent and 
the claimed effect (for the target group under the proposed conditions of use).  
Substantiation of the claim is dependent on a favourable outcome of the assessment of 1, 2 and 3 
above. Thus, a cause and effect relationship is considered not to be established if the outcome of any 
one of these assessments is unfavourable.  
For a claim, each relationship between a food/constituent and a claimed effect is assessed separately, 
and individual assessments are combined, as appropriate, to form coherent opinions. 
1. Characterisation of the food/constituent  
1.1. Fruits and/or vegetables (ID 1212, 1213, 1214, 1217, 1218, 1219, 1301, 1425, 1426, 1427, 
1428, 1429, 1430) 
The foods that are the subject of the health claims are “fruits (fresh, frozen, canned, bottled, dried, 
juiced)”, “fruit-rich diet”, “vegetables (fresh, frozen, canned, bottled, dried, juiced)”, “vegetable-rich 
diet”, and “fruits and vegetables” related to the following claimed effects: cardiac function, weight 
management, and blood glucose control. 
The macronutrient composition and energy density of different fruits and fruit products is widely 
variable. For example, fresh fruits generally have a low the energy density, have fructose as the 
                                                     
4  Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and 
health claims made on foods. OJ L 404, 30.12.2006, p. 9–25.  
5  EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), 2011. General guidance for stakeholders on the 
evaluation of Article 13.1, 13.5 and 14 health claims. EFSA Journal, 9(4):2135, 24 pp. 
6  See footnote 5 
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predominant sugar, and contain variable amounts of (generally soluble) dietary fibre, whereas the 
energy density of dried fruits is higher owing to dehydration; fruit juices can contain large amounts of 
added sugars, particularly glucose and sucrose, and the amount of dietary fibre is generally very low, 
unless it is added in the manufacturing process. The macronutrient composition and energy density of 
different vegetables and vegetable products is also widely variable. The energy density of fresh 
vegetables is generally low, and they contain variable amounts of dietary fibre, whereas processed 
vegetable products may contain considerable amounts of fat. Also the type and amount of vitamins, 
minerals, carotenoids and phenolic compounds contained in different types of fruits and vegetables is 
very variable.  
The Panel notes that the type and amount of the specific fruits/vegetables and/or of the fruit/vegetable 
products required to obtain the claimed effects have not been indicated in the information provided, 
and that the significant differences in composition existing between such fruit/vegetable products may 
have an impact on the claimed effects. The Panel also notes that the health effects of “fruit-rich” and 
“vegetable-rich” diets may depend on the overall characteristics (e.g. energy, energy density, and 
macronutrient composition) of such diets as influenced by other foods.  
The references submitted for the scientific substantiation of the health claims included narrative 
reviews and consensus opinions which addressed the association between dietary patterns and 
lifestyle factors (e.g. physical activity) on the risk of chronic disease, including coronary heart 
disease, obesity and type 2 diabetes (e.g. Lichtenstein et al., 2006; WHO/FAO, 2003). Dietary 
patterns which include a high consumption of fruits and vegetables have been associated with a 
decreased risk of chronic diseases (e.g. coronary heart disease, obesity and type 2 diabetes 
(WHO/FAO, 2003)) as compared to dietary patterns, amongst others, characterised by low 
consumption of fruits and vegetables (Lichtenstein et al., 2006; WHO/FAO, 2003). However, the food 
items which are included in the “fruit” and “vegetable” categories are generally not reported in these 
studies, and the evidence provided by these studies relates to overall dietary patterns rather than to an 
effect of “fruit” and “vegetable” consumption independent of other dietary modifications. 
Accordingly, dietary recommendations for the primary prevention of such diseases generally include 
consumption of a diet rich in fruits and vegetables, together with an appropriate intake of other foods 
to achieve dietary balance of fat/fatty acids, carbohydrates, adequate intake of dietary fibre and 
limited intake of sodium and alcohol. 
The references submitted also included human observational studies and narrative reviews on the 
association between dietary patterns and consumption of vitamins, minerals, carotenoids and phenolic 
compounds on the risk of chronic disease and on markers of oxidative stress; human intervention 
studies on the effects of different fruits and vegetables, and fruit and vegetable products (e.g. red 
grape fruit, citrus fruit, purple grape juice, strawberries, cherries, tea, and coffee) on platelet 
aggregation, markers of inflammation and oxidative damage to molecules; and references on the 
effects of plant food processing on the content and bioavailability of phenolic compounds in the final 
products (e.g. green beans, sweet corn, and lettuce).  
The Panel notes that most of the references provided have not characterised the intake of 
fruits/vegetables or of fruit/vegetable products by type and amount, or have not assessed the effects of 
fruit and vegetable consumption independent of other dietary modifications, but rather the effects of 
overall dietary patterns or the effects of specific food constituents (e.g. phenolic compounds and their 
classes, antioxidant vitamins, certain minerals, and dietary fibre) present in plant foods. The Panel 
also notes that the remaining references provided, which investigated the effects of a particular 
intervention on different health outcomes, referred to very specific food products, generally 
characterised by their antioxidant capacity in vitro or by their polyphenol content (and their classes), 
and that none of these studies addressed health outcomes related to normal cardiac function, body 
weight changes or blood glucose control.  
Fruit and/or vegetable and “Mediterranean diet” related health claims 
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The Panel considers that because of the high variety of the foods and food products that are the 
subject of the health claims, “fruits (fresh, frozen, canned, bottled, dried, juiced)”, “fruit-rich diet”, 
“vegetables (fresh, frozen, canned, bottled, dried, juiced)”, “vegetable-rich diet”, “fruits and 
vegetables”, these foods are not sufficiently characterised in relation to the claimed effects considered 
in this section.  
The Panel concludes that a cause and effect relationship cannot be established between the 
consumption of “fruits (fresh, frozen, canned, bottled, dried, juiced)”, “fruit-rich diet”, “vegetables 
(fresh, frozen, canned, bottled, dried, juiced)”, “vegetable-rich diet” or “fruits and vegetables” and the 
claimed effects considered in this section because of the insufficient characterisation of these food 
categories and diets. 
1.2. “Mediterranean diet” (ID 1423) 
The diet that is the subject of the health claim is the “Mediterranean diet” related to the following 
claimed effect: cardiac function.  
The characterisation provided by Member States specifies such diet as “based on high consumption of 
fruits, vegetables, cereals, pulses, nuts and seeds; moderate consumption of dairy products, fish, 
poultry and eggs and little use of red meat; low to moderate amount of wine; olive oil is the main 
cooking and dressing oil”. However, the Panel notes that quantitative amounts and appropriate 
characterisation of the food items or food groups listed have not been provided, and no reference to 
the macronutrient composition (including dietary fibre) of the diet has been made. The Panel also 
notes that wine, which is listed as one of the components of the “Mediterranean diet”, contains more 
than 1.2 % alcohol by volume and therefore should not bear health claims in accordance with 
Regulation (EC) No 1924/2006.  
Most of the references provided for the scientific substantiation of the claim reported on human 
observational studies which addressed the association between some dietary patterns defined as 
typical of the “Mediterranean diet”, or specific components of it, and different health outcomes, 
including blood lipids, blood pressure, obesity, incidence of coronary heart disease, and death from 
cardiovascular disease and from all causes. Human intervention studies on the effects on various 
health outcomes of different dietary interventions, collectively designated as the “Mediterranean 
diet”, have also been provided.  
In these studies, the characterisation of the “Mediterranean diet” is very variable. Some studies only 
referred to the fatty acid composition of the diet, or only considered the addition of nuts or wine 
(reviewed in Serra-Majem et al., 2006); other studies used the “Mediterranean Adequacy Index” 
obtained by dividing the sum of total energy percentages from food groups “typical of the reference 
Mediterranean diet” (i.e. bread, cereals, legumes, potatoes, vegetables, fresh fruit, fish, wine, 
vegetable oils) by the sum of the total energy percentage from food groups (milk, cheese, eggs, animal 
fats and margarines, sweet beverages, cakes/pie/cookies, sugar) “less typical” of the “reference 
Mediterranean diet” (Fidanza et al., 2004); finally, some studies used different scales indicating the 
degree of adherence to the “traditional Mediterranean diet” with scores which were either calculated 
on the basis of the mean consumption of a series of “food groups” (e.g. vegetables, legumes, fruits 
and nuts, cereal, fish, meat, poultry, and diary products) within the same study population 
(Panagiotakos et al., 2005; 2006a; 2006b; Psaltopoulou et al., 2004; Trichopoulou et al., 2003; 2005) 
or on the basis of fixed thresholds of intake using similar “food groups” (Estruch et al., 2006; 
Martinez-Gonzalez et al., 2004). 
The Panel notes that different dietary patterns exist in different Mediterranean countries (EFSA Panel 
on Dietetic Products Nutrition and Allergies (NDA), 2010). 
Fruit and/or vegetable and “Mediterranean diet” related health claims 
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The Panel notes that different definitions of “Mediterranean diet” have been used in the references 
provided, and that therefore the diet which is the subject of the health claim is unclear.  
The Panel considers that the diet, “Mediterranean diet”, which is the subject of the health claim, is not 
sufficiently characterised.  
The Panel concludes that a cause and effect relationship cannot be established between the 
consumption of a “Mediterranean diet” and the claimed effect considered in this section because of 
the insufficient characterisation of the term “Mediterranean diet”.  
CONCLUSIONS  
On the basis of the data presented, the Panel concludes that: 
Fruits and/or vegetables  
 The foods that are the subject of the health claims are “fruits (fresh, frozen, canned, bottled, dried, 
juiced)”, “fruit-rich diet”, “vegetables (fresh, frozen, canned, bottled, dried, juiced)”, “vegetable-
rich diet” and “fruits and vegetables” related to the following claimed effects: cardiac function, 
weight management, and blood glucose control. Because of the high variety of the foods and food 
products that are the subject of the health claims, “fruits (fresh, frozen, canned, bottled, dried, 
juiced)”, “fruit-rich diet”, “vegetables (fresh, frozen, canned, bottled, dried, juiced)”, “vegetable-
rich diet”, “fruits and vegetables”, these foods are not sufficiently characterised in relation to the 
claimed effects proposed.  
 A cause and effect relationship cannot be established between the consumption of “fruits (fresh, 
frozen, canned, bottled, dried, juiced)”, “fruit-rich diet”, “vegetables (fresh, frozen, canned, 
bottled, dried, juiced)”, “vegetable-rich diet” or “fruits and vegetables” and the claimed effects 
proposed because of the insufficient characterisation of these food categories and diets. 
“Mediterranean diet” 
 The diet that is the subject of the health claim, is the “Mediterranean diet” related to the following 
claimed effect: cardiac function. The “Mediterranean diet”, which is the subject of the health 
claim, is not sufficiently characterised.  
 A cause and effect relationship cannot be established between the consumption of a 
“Mediterranean diet” and the claimed effect proposed because of the insufficient characterisation 
of the term “Mediterranean diet”. 
DOCUMENTATION PROVIDED TO EFSA 
Health claims pursuant to Article 13 of Regulation (EC) No 1924/2006 (No: EFSA-Q-2008-1950, 
EFSA-Q-2008-1951, EFSA-Q-2008-1952, EFSA-Q-2008-1955, EFSA-Q-2008-1956, EFSA-Q-2008-
1957, EFSA-Q-2008-2039, EFSA-Q-2008-2160, EFSA-Q-2008-2162 ,EFSA-Q-2008-2163, EFSA-Q-
2008-2164, EFSA-Q-2008-2165, EFSA-Q-2008-2166, EFSA-Q-2008-2167). The scientific 
substantiation is based on the information provided by the Member States in the consolidated list of 
Article 13 health claims and references that EFSA has received from Member States or directly from 
stakeholders. 
The full list of supporting references as provided to EFSA is available on: 
http://www.efsa.europa.eu/panels/nda/claims/article13.htm. 
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APPENDICES 
APPENDIX A 
BACKGROUND AND TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
The Regulation 1924/2006 on nutrition and health claims made on foods
7
 (hereinafter "the 
Regulation") entered into force on 19
th
 January 2007. 
Article 13 of the Regulation foresees that the Commission shall adopt a Community list of permitted 
health claims other than those referring to the reduction of disease risk and to children's development 
and health. This Community list shall be adopted through the Regulatory Committee procedure and 
following consultation of the European Food Safety Authority (EFSA). 
Health claims are defined as "any claim that states, suggests or implies that a relationship exists 
between a food category, a food or one of its constituents and health". 
In accordance with Article 13 (1) health claims other than those referring to the reduction of disease 
risk and to children's development and health are health claims describing or referring to:  
a) the role of a nutrient or other substance in growth, development and the functions of the 
body; or 
b) psychological and behavioural functions; or 
c) without prejudice to Directive 96/8/EC, slimming or weight-control or a reduction in the 
sense of hunger or an increase in the sense of satiety or to the reduction of the available 
energy from the diet. 
To be included in the Community list of permitted health claims, the claims shall be: 
(i) based on generally accepted scientific evidence; and 
(ii) well understood by the average consumer. 
Member States provided the Commission with lists of claims as referred to in Article 13 (1) by 31 
January 2008 accompanied by the conditions applying to them and by references to the relevant 
scientific justification. These lists have been consolidated into the list which forms the basis for the 
EFSA consultation in accordance with Article 13 (3). 
ISSUES THAT NEED TO BE CONSIDERED 
IMPORTANCE AND PERTINENCE OF THE FOOD
8
  
Foods are commonly involved in many different functions
9
 of the body, and for one single food many 
health claims may therefore be scientifically true. Therefore, the relative importance of food e.g. 
nutrients in relation to other nutrients for the expressed beneficial effect should be considered: for 
functions affected by a large number of dietary factors it should be considered whether a reference to 
a single food is scientifically pertinent. 
                                                     
7 OJ L12, 18/01/2007 
8 The term 'food' when used in this Terms of Reference refers to a food constituent, the food or the food category.  
9 The term 'function' when used in this Terms of Reference refers to health claims in Article 13(1)(a), (b) and (c).  
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It should also be considered if the information on the characteristics of the food contains aspects 
pertinent to the beneficial effect. 
SUBSTANTIATION OF CLAIMS BY GENERALLY ACCEPTABLE SCIENTIFIC EVIDENCE 
Scientific substantiation is the main aspect to be taken into account to authorise health claims. Claims 
should be scientifically substantiated by taking into account the totality of the available scientific 
data, and by weighing the evidence, and shall demonstrate the extent to which: 
(a) the claimed effect of the food is beneficial for human health, 
(b) a cause and effect relationship is established between consumption of the food and the 
claimed effect in humans (such as: the strength, consistency, specificity, 
dose-response, and biological plausibility of the relationship), 
(c) the quantity of the food and pattern of consumption required to obtain the claimed 
effect could reasonably be achieved as part of a balanced diet, 
(d) the specific study group(s) in which the evidence was obtained is representative of the 
target population for which the claim is intended. 
EFSA has mentioned in its scientific and technical guidance for the preparation and presentation of 
the application for authorisation of health claims consistent criteria for the potential sources of 
scientific data. Such sources may not be available for all health claims. Nevertheless it will be 
relevant and important that EFSA comments on the availability and quality of such data in order to 
allow the regulator to judge and make a risk management decision about the acceptability of health 
claims included in the submitted list. 
The scientific evidence about the role of a food on a nutritional or physiological function is not 
enough to justify the claim. The beneficial effect of the dietary intake has also to be demonstrated. 
Moreover, the beneficial effect should be significant i.e. satisfactorily demonstrate to beneficially 
affect identified functions in the body in a way which is relevant to health. Although an appreciation 
of the beneficial effect in relation to the nutritional status of the European population may be of 
interest, the presence or absence of the actual need for a nutrient or other substance with nutritional or 
physiological effect for that population should not, however, condition such considerations. 
Different types of effects can be claimed. Claims referring to the maintenance of a function may be 
distinct from claims referring to the improvement of a function. EFSA may wish to comment whether 
such different claims comply with the criteria laid down in the Regulation. 
WORDING OF HEALTH CLAIMS 
Scientific substantiation of health claims is the main aspect on which EFSA's opinion is requested. 
However, the wording of health claims should also be commented by EFSA in its opinion. 
There is potentially a plethora of expressions that may be used to convey the relationship between the 
food and the function. This may be due to commercial practices, consumer perception and linguistic 
or cultural differences across the EU. Nevertheless, the wording used to make health claims should be 
truthful, clear, reliable and useful to the consumer in choosing a healthy diet. 
In addition to fulfilling the general principles and conditions of the Regulation laid down in Article 3 
and 5, Article 13(1)(a) stipulates that health claims shall describe or refer to "the role of a nutrient or 
other substance in growth, development and the functions of the body". Therefore, the requirement to 
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describe or refer to the 'role' of a nutrient or substance in growth, development and the functions of 
the body should be carefully considered. 
The specificity of the wording is very important. Health claims such as "Substance X supports the 
function of the joints" may not sufficiently do so, whereas a claim such as "Substance X helps 
maintain the flexibility of the joints" would. In the first example of a claim it is unclear which of the 
various functions of the joints is described or referred to contrary to the latter example which 
specifies this by using the word "flexibility". 
The clarity of the wording is very important. The guiding principle should be that the description or 
reference to the role of the nutrient or other substance shall be clear and unambiguous and therefore 
be specified to the extent possible i.e. descriptive words/ terms which can have multiple meanings 
should be avoided. To this end, wordings like "strengthens your natural defences" or "contain 
antioxidants" should be considered as well as "may" or "might" as opposed to words like 
"contributes", "aids" or "helps".  
In addition, for functions affected by a large number of dietary factors it should be considered 
whether wordings such as "indispensable", "necessary", "essential" and "important" reflects the 
strength of the scientific evidence. 
Similar alternative wordings as mentioned above are used for claims relating to different relationships 
between the various foods and health. It is not the intention of the regulator to adopt a detailed and 
rigid list of claims where all possible wordings for the different claims are approved. Therefore, it is 
not required that EFSA comments on each individual wording for each claim unless the wording is 
strictly pertinent to a specific claim. It would be appreciated though that EFSA may consider and 
comment generally on such elements relating to wording to ensure the compliance with the criteria 
laid down in the Regulation. 
In doing so the explanation provided for in recital 16 of the Regulation on the notion of the average 
consumer should be recalled. In addition, such assessment should take into account the particular 
perspective and/or knowledge in the target group of the claim, if such is indicated or implied. 
TERMS OF REFERENCE 
HEALTH CLAIMS OTHER THAN THOSE REFERRING TO THE REDUCTION OF DISEASE RISK AND TO 
CHILDREN'S DEVELOPMENT AND HEALTH 
EFSA should in particular consider, and provide advice on the following aspects: 
 Whether adequate information is provided on the characteristics of the food pertinent to the 
beneficial effect. 
 Whether the beneficial effect of the food on the function is substantiated by generally 
accepted scientific evidence by taking into account the totality of the available scientific data, 
and by weighing the evidence. In this context EFSA is invited to comment on the nature and 
quality of the totality of the evidence provided according to consistent criteria. 
 The specific importance of the food for the claimed effect. For functions affected by a large 
number of dietary factors whether a reference to a single food is scientifically pertinent. 
In addition, EFSA should consider the claimed effect on the function, and provide advice on the 
extent to which: 
 the claimed effect of the food in the identified function is beneficial. 
 a cause and effect relationship has been established between consumption of the food and the 
claimed effect in humans and whether the magnitude of the effect is related to the quantity 
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consumed. 
 where appropriate, the effect on the function is significant in relation to the quantity of the 
food proposed to be consumed and if this quantity could reasonably be consumed as part of a 
balanced diet.  
 the specific study group(s) in which the evidence was obtained is representative of the target 
population for which the claim is intended. 
 the wordings used to express the claimed effect reflect the scientific evidence and complies 
with the criteria laid down in the Regulation.  
When considering these elements EFSA should also provide advice, when appropriate: 
 on the appropriate application of Article 10 (2) (c) and (d) in the Regulation, which provides 
for additional labelling requirements addressed to persons who should avoid using the food; 
and/or warnings for products that are likely to present a health risk if consumed to excess. 
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APPENDIX B 
EFSA DISCLAIMER 
The present opinion does not constitute, and cannot be construed as, an authorisation to the marketing 
of the food/food constituent, a positive assessment of its safety, nor a decision on whether the 
food/food constituent is, or is not, classified as foodstuffs. It should be noted that such an assessment 
is not foreseen in the framework of Regulation (EC) No 1924/2006. 
It should also be highlighted that the scope, the proposed wordings of the claims and the conditions of 
use as proposed in the Consolidated List may be subject to changes, pending the outcome of the 
authorisation procedure foreseen in Article 13(3) of Regulation (EC) No 1924/2006. 
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APPENDIX C 
Table 1. Main entry health claims related to fruits and/or vegetables and to “Mediterranean diet”, 
including conditions of use from similar claims, as proposed in the Consolidated List. 
ID Food or Food constituent Health Relationship Proposed wording 
1212 Fruits (fresh, frozen, 
canned, bottled, dried, 
juiced). 
Heart health. 
Clarification provided 
Contribute and support 
cardiovascular/heart 
health (WHO Report 
2003, cpt 5.4, table 10): 
Promote and mantain 
cardiovascolar health via 
the action of 
phytochemicals eating at 
least 400g/day of fruit 
and vegetables. 
Diets rich in fruit promote heart 
health. 
Conditions of use 
- 5 a day (80g = 1 portion; only one portion can be juice at 150ml) 
- At least 400 g/day of fruit and vegetables, at least 5 portions/day 
ID Food or Food constituent Health Relationship Proposed wording 
1213 Fruits (fresh, frozen, 
canned, bottled, dried, 
juiced). 
Weight management via 
fibre. 
Clarification provided 
Weight control via 
dietary fibre and satiety 
(WHO report 2003 table 
7 and Annex: Summary 
of evidence). 
A diet rich in fruits helps to manage 
body weight. 
Conditions of use 
- 5 a day (80g = 1 portion; only one portion can be juice at 150ml). 
- At least 400 g/day of fruit and vegetables, at least 5 portions/day. 
ID Food or Food constituent Health Relationship Proposed wording 
1214 Fruits (fresh, frozen, 
canned, bottled, dried, 
juiced). 
Modulation of glycemic 
response. 
A diet rich in fruits helps to control 
blood glucose level. 
Conditions of use 
- 5 a day (80g = 1 portion; only one portion can be juice at 150ml). 
- At least 400 g/day of fruit and vegetables, at least 5 portions/day. 
ID Food or Food constituent Health Relationship Proposed wording 
1217 Vegetables (fresh, frozen, 
canned, bottled, dried, 
juiced). 
Heart health. 
Clarification provided 
A diet rich in vegetables promotes 
heart health. 
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Promote and mantain 
cardiovascular health via 
the action of 
phytochemicals eating at 
least 400g/day of fruit 
and vegetables. 
Conditions of use 
- 5 a day (80g = 1 portion; only one portion can be juice at 150ml). 
ID Food or Food constituent Health Relationship Proposed wording 
1218 Vegetables (fresh, frozen, 
canned, bottled, dried, 
juiced). 
Weight management via 
fibre. 
Clarification provided 
Weight control via 
dietary fibre and satiety 
(WHO report 2003 table 
7 and Annex: Summary 
of evidence). 
A diet rich in vegetables helps to 
manage body weight. 
Conditions of use 
- 5 a day (80g = 1 portion; only one portion can be juice at 150ml). 
ID Food or Food constituent Health Relationship Proposed wording 
1219 Vegetables (fresh, frozen, 
canned, bottled, dried, 
juiced). 
Modulation of glycemic 
response. 
A diet rich in vegetables helps to 
control blood glucose level. 
Conditions of use 
- 5 a day (80g = 1 portion; only one portion can be juice at 150ml). 
ID Food or Food constituent Health Relationship Proposed wording 
1301 Fruits and vegetables. Heart and cardiovascu-
lar system. 
Clarification provided 
In the frame of healthy 
diet consumption of at 
least 400 g/day fruit and 
vegetable is suggested. 
Fibres, antioxodant 
vitamins and minerals 
and other bioactive 
substances (polyphenols, 
phytosterines,saponines, 
ect.) can affect the 
circulatory system 
(heart, wessels, blood 
parameters) in a positive 
way. 
Regular consumption of fruit and 
vegetables support the heart and 
cardiovascular health. 
Conditions of use 
- Regular consumption several times a day, together >400 g/day. 
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Comments from Member States 
This health relationship can be classified as a general dietary guideline, but as a part of 
commercial communication it should be handled under Reg. 1924/2006/EK. 
ID Food or Food constituent Health Relationship Proposed wording 
1423 Mediterranean diet. Related to 
cardiovascular health. 
Clarification provided 
Sustains/ supports 
cardiovascular health: 
for example, may help 
maintain a normal blood 
pressure and normal 
cholesterol levels and 
trials show reduced 
incidence and 
prevelance of cardiac 
events in subjects on a 
Mediterranean diet 
compared to controls. 
Such a diet is based on 
high consumption of 
fruits, vegetables, 
cereals, pulses, nuts and 
seeds; moderate 
consumption of dairy 
products, fish, poultry 
and eggs and little use of 
red meat; low to 
moderate amount of 
wine; olive oil is the 
main cooking and 
dressing oil. 
'X' fits in a Mediterranean diet. A 
Mediterranean style diet helps 
maintain heart health. 
Conditions of use 
- See reference section for dietary characteristics. Product should provide at least a serving of 
fruit and/or vegetables and/or meet the conditions of use for unsaturated fatty acids. 
ID Food or Food constituent Health Relationship Proposed wording 
1425 Fruit-rich diet. Heart health. 
Clarification provided 
Contribute and support 
cardiovascular/heart 
health (WHO Report 
2003, cpt 5.4, table 10). 
A diet rich in fruit promotes heart 
health. 
Conditions of use 
- At least 400 g/day of fruit and vegetables, at least 5 portions/day. 
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ID Food or Food constituent Health Relationship Proposed wording 
1426 Fruit-rich diet. Weight management via 
fibre. 
A diet rich in fruits can help to 
control body weight. 
Conditions of use 
- At least 400 g/day of fruit and vegetables, at least 5 portions/day. 
ID Food or Food constituent Health Relationship Proposed wording 
1427 Fruit-rich diet. Modulation of glycemic 
response. 
A diet rich in fruits helps to control 
blood glucose level. 
Conditions of use 
- At least 400 g/day of fruit and vegetables, at least 5 portions/day 
ID Food or Food constituent Health Relationship Proposed wording 
1428 Vegetable-rich diet. Heart health. 
Clarification provided 
Contribute and support 
cardiovascular/heart 
health (WHO Report 
2003, cpt 5.4, table 10). 
Diets rich in vegetables promote heart 
health. 
Conditions of use 
- At least 400 g/day of fruit and vegetables, at least 5 portions/day. 
ID Food or Food constituent Health Relationship Proposed wording 
1429 Vegetable-rich diet. Weight management via 
fibre. 
A diet rich in vegetables helps 
controlling body weight. 
Conditions of use 
- At least 400 g/day of fruit and vegetables, at least 5 portions/day. 
ID Food or Food constituent Health Relationship Proposed wording 
1430 Vegetable-rich diet. Modulation of glycemic 
response. 
A diet rich in vegetables helps 
controlling blood glucose level. 
Conditions of use 
- At least 400 g/day of fruit and vegetables, at least 5 portions/day. 
 
